| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-205-08 | 59651-205 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET | ORAL | 20180417 | N/A | ANDA | ANDA210604 | Aurobindo Pharma Limited | CAPECITABINE | 500 mg/1 | 120 TABLET in 1 BOTTLE (59651-205-08) |
| 59651-205-10 | 59651-205 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET | ORAL | 20180417 | N/A | ANDA | ANDA210604 | Aurobindo Pharma Limited | CAPECITABINE | 500 mg/1 | 1 BLISTER PACK in 1 CARTON (59651-205-10) / 10 TABLET in 1 BLISTER PACK |
| 59651-204-10 | 59651-204 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET | ORAL | 20180417 | N/A | ANDA | ANDA210604 | Aurobindo Pharma Limited | CAPECITABINE | 150 mg/1 | 1 BLISTER PACK in 1 CARTON (59651-204-10) / 10 TABLET in 1 BLISTER PACK |
| 59651-204-60 | 59651-204 | HUMAN PRESCRIPTION DRUG | Capecitabine | Capecitabine | TABLET | ORAL | 20180417 | N/A | ANDA | ANDA210604 | Aurobindo Pharma Limited | CAPECITABINE | 150 mg/1 | 60 TABLET in 1 BOTTLE (59651-204-60) |